Office of the Director, National Institutes of Health; Amended Notice of Meeting, 67883 [06-9387]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 226 / Friday, November 24, 2006 / Notices
Dated: November 16, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9385 Filed 11–22–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 16, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9382 Filed 11–22–06; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
cprice-sewell on PROD1PC66 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Revised Unsolicited
Complement Program Project Review.
Date: December 12, 2006.
Time: 1 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Room 3118, Bethesda, MD 20817, (Telephone
Conference Call).
Contact Person: Quirjin Vos, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892, 301–451–2666, qvos@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Clinical Trial for
Community-Acquired Methicillin Resistant
Staphylococcus Aureus Infections.
Date: December 18, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Lynn Rust, PhD., Scientific
Review Administrator, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892, 301–402–3938, lr228v@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Alergy, Immunology,
13:24 Nov 22, 2006
Dated: November 16, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9387 Filed 11–22–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
VerDate Aug<31>2005
67883
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Aging Special Emphasis Panel,
December 4, 2006, 7 p.m. to December
5, 2006 6 p.m. Holiday Inn Chevy
Chase, 5520 Wisconsin Avenue, Chevy
Chase, MD 20815 which was published
in the Federal Register on November 3,
2006, Vol. 71/64730.
The meeting will now be held at the
Hilton San Diego Airport Hotel, San
Diego, California from December 4–5,
2006. The meeting is closed to the
public.
Dated: November 16, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9386 Filed 11–22–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the Recombinant DNA
Advisory Committee, December 5, 2006,
8 a.m. to December 6, 2006, 6 p.m.,
National Institutes of Health, Building
31, 31 Center Drive, Bethesda, MD
20892 which was published in the
Federal Register on November 13, 2006,
71 FR 218, page 66180.
The meeting of the Recombinant DNA
Advisory Committee will begin on
December 5 at 12 noon and will end
December 6, 2006 at 6 p.m. instead of
8 a.m. to 6 p.m. The meeting is open to
the public.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Skeletal Muscle and Exercise
Physiology.
Date: November 28, 2006.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: John P. Holden, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4016J,
MSC 7814, Bethesda, MD 20892, 301–496–
8551. holdenjo@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Clinical
Neuroscience and Disease.
Date: November 28, 2006.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Rene Etcheberrigaray, MD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5196,
MSC 7846, Bethesda, MD 20892, (301) 435–
1246, etcheber@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
E:\FR\FM\24NON1.SGM
24NON1
]]>Agencies
[Federal Register Volume 71, Number 226 (Friday, November 24, 2006)]
[Notices]
[Page 67883]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9387]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the
Recombinant DNA Advisory Committee, December 5, 2006, 8 a.m. to
December 6, 2006, 6 p.m., National Institutes of Health, Building 31,
31 Center Drive, Bethesda, MD 20892 which was published in the Federal
Register on November 13, 2006, 71 FR 218, page 66180.
The meeting of the Recombinant DNA Advisory Committee will begin on
December 5 at 12 noon and will end December 6, 2006 at 6 p.m. instead
of 8 a.m. to 6 p.m. The meeting is open to the public.
Dated: November 16, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9387 Filed 11-22-06; 8:45 am]
BILLING CODE 4140-01-M
